Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001104659-19-039024

Options or other derivatives

  • Director acquired 2,323 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gutry Phil · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-06-28 Grant or award : show line 1 in the form Stock Option (Right to Buy) +2,323 $5.44 2029-06-28 2,323 2,323 D
Loading xslF345X03/a4.xml…